Keyword: GlaxoSmithKline (GSK)

News

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

19.01.2013 - Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

China to Cut Prices of More than 400 Drugs from February

08.01.2013 - China will cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20% from February, in a move to make medicines, including some products from Pfizer...

News

Entering the Age of the $1 Million Medicine

03.01.2013 - The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...

News

Number of New Drugs Picks Up in Europe and U.S.

19.12.2012 - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...

News

Drug Industry Treading Water on R&D Productivity

04.12.2012 - Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...

News

GSK and J&J Lead Rivals in Drug Access for Poor

28.11.2012 - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...

News

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale

27.11.2012 - Merck KGaA said it would keep its non-prescription drugs unit even as a tussle over vitamin maker Schiff Nutrition highlighted the rich sale premium it could fetch. Merck's...